Didžioji Britanija - anglų - myHealthbox

crescent pharma limited - ascorbic acid - tablets - 100mg - ascorbic acid (vit c), plain - for the treatment of scurvy. prophylactically in cases where deficiency might be expected to occur

Didžioji Britanija - anglų - myHealthbox

crescent pharma limited - ascorbic acid - tablets - 200mg - ascorbic acid (vit c), plain - for use in vitamin c deficiency including the treatment and prevention of scurvy

Jungtinės Valstijos - anglų - NLM (National Library of Medicine)

fisiopharma srl - ascorbic acid (unii: pq6ck8pd0r) (ascorbic acid - unii:pq6ck8pd0r) - ascorbic acid is recommended for the prevention and treatment of scurvy. its parenteral administration is desirable for patients with an acute deficiency or for those whose absorption of orally ingested ascorbic acid is uncertain. symptoms of mild deficiency may include faulty bone and tooth development, gingivitis, bleeding gums, and loosened teeth. febril states, chronic illness, and infection (pneumonia, whooping cough, tuberculosis, diphtheria, sinusitis, rheumatic fever, etc.) increases the need for ascorbic acid. hemovascular disorders, burns, delayed fracture and wound healing are indications for an increase in the daily intake. there are no contraindications to the administration of ascorbic acid

Jungtinės Valstijos - anglų - NLM (National Library of Medicine)

the torrance company - ascorbic acid (unii: pq6ck8pd0r) (ascorbic acid - unii:pq6ck8pd0r) - ascorbic acid is recommended for the prevention and treatment of scurvy. its parenteral administration is desirable for patients with an acute deficiency or for those whose absorption of orally ingested ascorbic acid is uncertain. symptoms of mild deficiency may include faulty bone and tooth development, gingivitis, bleeding gums, and loosened teeth. febrile states, chronic illness, and infection (pneumonia, whooping cough, tuberculosis, diphtheria, sinusitis, rheumatic fever, etc.) increases the need for ascorbic acid. hemovascular disorders, burns, delayed fracture and wound healing are indications for an increase in the daily intake. there are no contraindications to the administration of ascorbic acid.

Jungtinės Valstijos - anglų - NLM (National Library of Medicine)

mylan institutional llc - ascorbic acid (unii: pq6ck8pd0r) (ascorbic acid - unii:pq6ck8pd0r) - ascorbic acid is recommended for the prevention and treatment of scurvy. its parenteral administration is desirable for patients with an acute deficiency or for those whose absorption of orally ingested ascorbic acid is uncertain. symptoms of mild deficiency may include faulty bone and tooth development, gingivitis, bleeding gums, and loosened teeth. febril states, chronic illness, and infection (pneumonia, whooping cough, tuberculosis, diphtheria, sinusitis, rheumatic fever, etc.) increases the need for ascorbic acid. hemovascular disorders, burns, delayed fracture and wound healing are indications for an increase in the daily intake. there are no contraindications to the administration of ascorbic acid.

Didžioji Britanija - anglų - MHRA (Medicines & Healthcare Products Regulatory Agency)

alliance healthcare (distribution) ltd - ascorbic acid - chewable tablet - 500mg

Didžioji Britanija - anglų - MHRA (Medicines & Healthcare Products Regulatory Agency)

medihealth (northern) ltd - ascorbic acid - oral tablet - 500mg

Jungtinės Valstijos - anglų - NLM (National Library of Medicine)

deseret biologicals, inc. - ascorbic acid (unii: pq6ck8pd0r) (ascorbic acid - unii:pq6ck8pd0r) - ascorbic acid 6 [hp_x] in 1 ml - for temporary relief of symptoms of vitamin c deficiency such as lack of energy, weakness, swollen and tender joints. for temporary relief of symptoms of vitamin c deficiency such as lack of energy, weakness, swollen and tender joints.

Jungtinės Valstijos - anglų - NLM (National Library of Medicine)

guna spa - ascorbic acid (unii: pq6ck8pd0r) (ascorbic acid - unii:pq6ck8pd0r), sus scrofa conjunctiva (unii: w61me6q717) (sus scrofa conjunctiva - unii:w61me6q717), prasterone (unii: 459ag36t1b) (prasterone - unii:459ag36t1b), malic acid (unii: 817l1n4ckp) (malic acid - unii:817l1n4ckp), fucus vesiculosus (unii: 535g2abx9m) (fucus vesiculosus - unii:535g2abx9m), histidine monohydrochloride (unii: 1d5q932xm6) (histidine - unii:4qd397987e), hyaluronidase (unii: 8kog53z5em) (hyaluronidase - unii:8kog53z5em), human - ascorbic acid 4 [hp_x] in 30 ml - ascorbic acid 4x antioxidant conjunctiva tissue 6x detoxification dehydroepiandrosteron 6x hormonal support dl-malic acid 6x promote cell metabolism fucus vesiculosus 4x detoxification histidine 4x anti-inflammatory hyaluronidase 6x anti-inflammatory interleukin 6 4c immune support lacticum acidum 4x antioxidant lymphatic vessel 6x immune support nadidum 6x metabolic support natrum oxalaceticum 6x antioxidant natrum pyruvicum 6x antioxidant natrum sulphuricum 6x, 8x, 12x, 30x, 200x antioxidant phenylalanine 4x improve concentration prolactin 6x improve concentration

Belgija - anglų - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

lambo laboratoria sa-nv - ascorbic acid 97,5 % - eq. ascorbic acid 100 % - compressed lozenge - 500 mg - ascorbic acid 550 mg - ascorbic acid (vit c)